tm logo
VITASIRO
FORMALIZED

on 29 Jan 2024

Last Applicant/ Owned by

CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD.

491B River Valley Road, #06-01 Valley PointSingapore, 248373

SG

Serial Number

2307311 filed on 29th Jan 2024

Correspondent Address

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

CA

H3B4M4

VITASIRO

Trademark usage description

biological preparations for use in industry and science, other than for medical or veterinary purposes; chemical preparations for use in science, name Read More

Classification Information


Class [001]
Biological preparations for use in industry and science, other than for medical or veterinary purposes; Chemical preparations for use in science, namely, the extraction of DNA, RNA, pathogens, proteins and other biological tissues other than for medical or veterinary purposes; Reagents for use in scientific apparatus for chemical analyses; Chemical reagents, other than for medical or veterinary purposes; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Reagents for scientific purposes for laboratory use; Chemical reagents for scientific purposes; Reagents for in-vitro laboratory use, other than for medical or veterinary purposes; Magnetic fluid for industrial purposes; Diagnostic preparations for laboratory use, other than for medical or veterinary purposes; Nucleic acid amplification reagents for scientific purposes; Nucleic acid extraction reagents for scientific purposes; Nucleic acid detection reagents for scientific purposes.


Classification kind code

12

Class [005]
Diagnostic preparations for veterinary purposes; Diagnostic preparations for medical purposes; Chemical reagent mixtures in kit form for medical use, namely, in-vitro diagnostic (IVD) disease testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Diagnostic reagents for medical use for sale in kit form, namely, in-vitro diagnostic (IVD) kits consisting primarily of nucleotide, primers, probes, polymerase, buffers, and reagents for use in disease testing by sample preparation, nucleic purification and amplification, and optical detection; Nucleic acid amplification reagents for medical use; Nucleic acid extraction reagents for medical use; Nucleic acid detection reagents for medical use; Diagnostic test kits comprising diagnostic agents, preparations and substances for detecting COVID-19 and other coronavirus diseases; Reagents for use in medical testing for COVID-19 and other coronavirus diseases.


Classification kind code

12

Class [009]
Chemistry apparatus and instruments; Apparatus for scientific research in laboratories, namely, apparatus for extracting DNA and RNA from the susceptible body fluids; Test tubes; Polymerase chain reaction (PCR) apparatus for measuring the DNA and RNA level of the susceptible body fluids; Apparatus for use in laboratory analysis for extracting the DNA and RNA from the susceptible body fluids; Bioreactors for laboratory use; Cartridges for scientific use in nucleic acid extraction and amplification and detection.


Classification kind code

12

Class [010]
Veterinary diagnostic apparatus for testing the DNA and RNA level of pathogens and other biological tissues; Diagnostic apparatus for medical purposes for testing the DNA and RNA level of pathogens and other biological tissues; Medical test equipment for bioanalysis of body fluids incorporating a cartridge for sample preparation, nucleic acid purification and amplification, and optical detection; Medical devices for the qualitative detection of COVID-19 and other coronavirus antibodies in human specimens collected as plasma or dried blood spots; Polymerase chain reaction (PCR) tests for the detection of viruses in humans.


Classification kind code

12

Mark Details


Serial Number

2307311

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 08th Feb 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 29th Jan 2024
Filed
Submitted for opposition 1
on 29th Jan 2024
Created
Submitted for opposition 31
on 29th Jan 2024
Formalized